DailyDoctor Archive Specialties Get app
All pathology briefings

The edition · Pathology

Releasing the tourniquet at the first tube cut haemolysed emergency samples by a third

A randomised phlebotomy trial targets the commonest pre-analytical error, short-course endocrine therapy is shown to change breast resection grading, TFEB RNA-ISH separates a rare renal tumour from its mimics, and seven experts rarely agreed on goblet cell adenocarcinoma grade.

The edition in brief

In a randomised trial of 790 adult emergency patients of non-critical acuity, starting cuff release as blood entered the first tube reduced haemolysed serum samples from 26.1% to 17.2% (absolute reduction 8.9 points, 95% CI 3.1-14.5; NNT about 11). The result applies to direct 21-gauge venepuncture at a standard 60 mm Hg, not catheter draws or elastic tourniquets. In 180 women given a median 29 days of preoperative endocrine therapy for ER-positive, HER2-negative breast cancer, Ki67 fell to 10% or below in 73.9%, and histological grade fell in 36.7% against 7.9% of untreated controls; PR expression often fell and HER2-low status became more frequent. Among renal tumours, TFEB RNA-ISH stained all 16 TFEB-altered carcinomas and none of the controls, including TFE3-rearranged tumours, while cathepsin K and GPNMB lacked specificity. And seven pathologists agreed on the WHO three-tier grade in only 4 of 20 appendiceal goblet cell adenocarcinomas (kappa 0.29).

In this edition

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for pathology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free